Paying users zone. Data is hidden behind hidden.

  • Get 1-month access to Bristol-Myers Squibb Co. for $19.99, or

  • get full access to the entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Microsoft Excel LibreOffice Calc

Bristol-Myers Squibb Co. (BMY)


Cash Flow Statement

Beginner level

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company’s balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Bristol-Myers Squibb Co., consolidated cash flow statement

US$ in millions

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net earnings
Depreciation and amortization, net
Deferred income taxes
Stock-based compensation
Impairment charges
Pension settlements and amortization
Divestiture gains and royalties
Asset acquisition charges
Equity investment (gains) losses
Contingent consideration fair value adjustments
Other adjustments
Receivables
Inventories
Accounts payable
Deferred income
Income taxes payable
Other
Changes in operating assets and liabilities
Adjustments to reconcile net earnings to net cash provided by operating activities
Net cash provided by operating activities
Sale and maturities of marketable debt securities
Purchase of marketable debt securities
Capital expenditures
Divestiture and other proceeds
Acquisition and other payments, net of cash acquired
Net cash (used in) provided by investing activities
Short-term debt obligations, net
Issuance of long-term debt
Repayment of long-term debt
Repurchase of common stock
Dividends
Other
Net cash provided by (used in) financing activities
Effect of exchange rates on cash, cash equivalents and restricted cash
Increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of year

Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).

Cash flow statement item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Bristol-Myers Squibb Co.’s net cash provided by operating activities increased from 2017 to 2018 and from 2018 to 2019.
Net cash (used in) provided by investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Bristol-Myers Squibb Co.’s net cash (used in) provided by investing activities decreased from 2017 to 2018 and from 2018 to 2019.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Bristol-Myers Squibb Co.’s net cash provided by (used in) financing activities increased from 2017 to 2018 and from 2018 to 2019.